trending Market Intelligence /marketintelligence/en/news-insights/trending/yizrbbcasbhswieyxzodug2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

VistaGen Therapeutics raises $2.3M from private placement

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


VistaGen Therapeutics raises $2.3M from private placement

VistaGen Therapeutics Inc. raised about $2.3 million from its private placement to individual investors.

The California-based company sold about 1.8 million units for $1.25 apiece.

Each unit consisted of one unregistered common share and a warrant to buy 1 unregistered common stock for $1.50 per share.

The company intends to use the proceeds for general working capital purposes.

VistaGen develops and commercializes medicines for depression and other central nervous system disorders.